Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Salib Oncology, Easton

Miami Cancer Center, Miami

Lynn Cancer Center, Boca Raton

Daycare Angels under AOH, Mumbai

Norton Cancer Institute - Downtown, Louisville

University of Wisconsin Carbone Cancer Center, Madison

Washington University - Siteman Cancer Center, St Louis

Los Angeles Hematology Oncology Medical Group, Los Angeles

Providence Medical Foundation -Fullerton, Fullerton

Grant Medical Foundation Ruby Hall Clinic, Pune

University of Maryland Greenebaum Cancer Center, Baltimore

Dartmouth Hitchcock Medical Center, Lebanon